A detailed history of Loomis Sayles & CO L P transactions in Novo Nordisk A S stock. As of the latest transaction made, Loomis Sayles & CO L P holds 8,623,915 shares of NVO stock, worth $733 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
8,623,915
Previous 8,897,437 3.07%
Holding current value
$733 Million
Previous $1.27 Billion 19.15%
% of portfolio
1.35%
Previous 1.75%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $32.6 Million - $39.8 Million
-273,522 Reduced 3.07%
8,623,915 $1.03 Billion
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $5.51 Million - $6.6 Million
44,905 Added 0.51%
8,897,437 $1.27 Billion
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $15.4 Million - $20.5 Million
-150,793 Reduced 1.67%
8,852,532 $1.14 Billion
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $8.29 Million - $9.96 Million
-94,483 Reduced 1.04%
9,003,325 $931 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $396 Million - $868 Million
4,350,862 Added 91.66%
9,097,808 $827 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $20.2 Million - $22.4 Million
-129,714 Reduced 2.66%
4,746,946 $768 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $13.6 Million - $16.4 Million
-103,130 Reduced 2.07%
4,876,660 $776 Million
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $20.3 Million - $26.7 Million
-197,599 Reduced 3.82%
4,979,790 $674 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $13.2 Million - $16.2 Million
-138,349 Reduced 2.6%
5,177,389 $516 Million
Q2 2022

Aug 05, 2022

SELL
$103.24 - $121.81 $60.6 Million - $71.6 Million
-587,411 Reduced 9.95%
5,315,738 $592 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $23.6 Million - $28.5 Million
-253,679 Reduced 4.12%
5,903,149 $656 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $27.1 Million - $33 Million
-282,261 Reduced 4.38%
6,156,828 $690 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $3.12 Million - $3.94 Million
36,939 Added 0.58%
6,439,089 $618 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $18.5 Million - $23.2 Million
-273,225 Reduced 4.09%
6,402,150 $536 Million
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $10 Million - $11.3 Million
-149,281 Reduced 2.19%
6,675,375 $450 Million
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $29.1 Million - $33.6 Million
-454,915 Reduced 6.25%
6,824,656 $477 Million
Q3 2020

Nov 12, 2020

SELL
$63.69 - $70.22 $5.43 Million - $5.99 Million
-85,286 Reduced 1.16%
7,279,571 $505 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $531 Million - $616 Million
-9,068,788 Reduced 55.18%
7,364,857 $482 Million
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $263 Million - $345 Million
-5,326,826 Reduced 24.48%
16,433,645 $989 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $36.4 Million - $42.6 Million
730,735 Added 3.47%
21,760,471 $1.26 Billion
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $6.99 Million - $7.85 Million
146,969 Added 0.7%
21,029,736 $1.09 Billion
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $160,068 - $179,499
-3,421 Reduced 0.02%
20,882,767 $1.07 Billion
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $6.79 Million - $7.71 Million
146,494 Added 0.71%
20,886,188 $1.09 Billion
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $41.7 Million - $47.4 Million
-1,002,835 Reduced 4.61%
20,739,694 $955 Million
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $21.4 Million - $23.4 Million
457,466 Added 2.15%
21,742,529 $1.02 Billion
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $32.8 Million - $37.3 Million
-740,050 Reduced 3.36%
21,285,063 $982 Million
Q1 2018

May 11, 2018

BUY
$48.49 - $58.14 $64.2 Million - $77 Million
1,323,857 Added 6.4%
22,025,113 $1.08 Billion
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $8.22 Million - $9.29 Million
172,851 Added 0.84%
20,701,256 $1.11 Billion
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $19.4 Million - $23.2 Million
472,170 Added 2.35%
20,528,405 $988 Million
Q2 2017

Aug 14, 2017

BUY
N/A
20,056,235
20,056,235 $860 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.